Magle Chemoswed Holding AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MAGLE.ST research report →
Companywww.maglechemoswed.com
Magle Chemoswed Holding AB (publ) engages in the research, development, and manufacturing in the areas of pharmaceutical chemistry and pharmaceutical technology in Sweden. The company focuses on the process development and manufacture of active pharmaceutical ingredients (API); and research, development, and production of products in the areas of wound care and diagnostics with a focus on products based on degradable starch microspheres. Its APIs include Warfarin sodium products that are used as anticoagulants for multiple indications; Melperone hydrochloride, which is an antipsychotic agent; Isradipine, a calcium channel blocker used to treat hypertension; Amantadine sulfate that is used in the treatment of central nervous system disorders; and Benserazide hydrochloride, which is used in combination with L-Dopa in the treatment of Parkinson's disease.
- CEO
- Aaron Wong
- IPO
- 2020
- Employees
- 147
- HQ
- Malmö, SE
Price Chart
Valuation
- Market Cap
- $84.66M
- P/E
- -0.53
- P/S
- 0.30
- P/B
- 0.21
- EV/EBITDA
- -19.05
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 82.15%
- Op Margin
- -45.63%
- Net Margin
- -56.51%
- ROE
- -31.87%
- ROIC
- -15.89%
Growth & Income
- Revenue
- $282.92M · 19.86%
- Net Income
- $-159,885,000 · -1439.52%
- EPS
- $-7.74 · -932.26%
- Op Income
- $-135,984,000
- FCF YoY
- -14.64%
Performance & Tape
- 52W High
- $30.00
- 52W Low
- $3.68
- 50D MA
- $5.02
- 200D MA
- $13.98
- Beta
- 0.51
- Avg Volume
- 7.39K
Get TickerSpark's AI analysis on MAGLE.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our MAGLE.ST Coverage
We haven't published any research on MAGLE.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MAGLE.ST Report →